Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.
about
Addressing tobacco in managed care: results of the 2002 survey.The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of EvidenceElectronic cigarettes for smoking cessationThe global tobacco disease pandemic: nature, causes, and cures.Management of lung cancerCost-effectiveness of extended cessation treatment for older smokersInvesting in youth tobacco control: a review of smoking prevention and control strategies.Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice.Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.Addressing tobacco in managed care: results of the 2003 surveyGuidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority.Nicotine replacement therapy for the palliation of nicotine abstinence syndrome: boon more than bane.Factors Associated with Smoking Cessation Among Quit Smart(™) Participants.Cost effectiveness analysis of smoking cessation interventions.Cost-effectiveness of smoking cessation to prevent age-related macular degeneration.Cost effectiveness of the Oregon quitline "free patch initiative".Cost-effectiveness of smoking cessation and the implications for COPD.A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol.The effectiveness of covering smoking cessation services for medicare beneficiaries.A review of economic evaluations of tobacco control programs.The effect of removing cost as a barrier to treatment initiation with outpatient tobacco dependence clinics among emergency department patients.Helping smokers quit: understanding the barriers to utilization of smoking cessation servicesTreatment seeking for smoking cessation among young adults.Pharmacotherapy for smoking cessation.Economic evaluation of pharmaco- and behavioral therapies for smoking cessation: a critical and systematic review of empirical research.The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Smoking, Mental Illness, and Public Health.Quitline in smoking cessation: a cost-effectiveness analysis.Lung Cancer Screening and Smoking Cessation Clinical Trials: SCALE Collaboration.Smoking, healthcare cost, and loss of productivity in Sweden 2001.Pattern of medical charges after quitting smoking among those with and without arthritis, allergies, or back pain.The dirty dozen: 12 myths that undermine tobacco control.The role of research in international tobacco control.
P2860
Q24811284-3F4FC0DC-9836-43A3-BAB0-2B85680BC352Q26799108-53AFDE73-79FF-4369-9A6C-CB3E8ABBDB1AQ28249549-79C79C70-F5E6-4A1C-8B87-3A1416665441Q30374433-AB4B7DC2-EF26-4C80-A2F6-4AB25A99F2F0Q33583714-B663BB5E-B243-4B62-92F0-51628AB1F1FEQ33610016-A8E5B920-9282-4499-A1AE-B7F188AFEE94Q33848364-167C7ED7-D4F1-4D2B-833D-54E520B2A990Q34945065-BCBAFC79-D868-42B7-8CDC-41D267751B1DQ35031656-5F8BBB1E-1A22-46C6-84BD-1F833E50B0F0Q35072665-65635527-6432-4F49-ACC2-F3CA6EE32281Q35131302-190EBDF2-F37C-48AB-91D6-B7ECE4749898Q35577236-A5A9A533-122F-4EA9-B470-580A970E89A8Q35636043-A8E1265B-2950-414B-B4A1-61E5BAF9877DQ36403028-CC00409E-37A9-4E0C-A294-59079562FC78Q36638298-197AB167-98FF-4A41-9003-0A62B2C70339Q36924878-9F517054-840C-44E9-8E28-621AC0238AD8Q37005826-69E6FE4E-29AA-481A-9257-B8FB732DD8D7Q37018832-55C3FB89-84D3-4FF8-861A-74CA23356398Q37033602-78509B6C-599A-408C-84DD-E06E931016A2Q37037392-DAAB8A0D-AC35-4624-AF96-4E331FEF1434Q37167092-1160D8F5-4C5D-4004-A0AA-DD09EF9796BFQ37182930-3AB1DDDD-6BDB-4DC7-9FA4-66DFBD27671CQ37212193-732B5C88-9773-4D5C-8814-DA49D344EF3EQ37359906-51AD4943-C099-41A1-BDB4-68D6DFAFB3CCQ37362638-ED64F44C-3E65-4A38-9CDE-EF4DDC7BFBDCQ37648843-52890B0F-1D4F-4659-A6C6-BCE5539C36EFQ38167693-EC025D62-A85D-4BB7-9988-AA385215215EQ39043292-87E41A29-9811-41BA-A422-343EC301CA4AQ45194574-32818B3A-E734-484E-B6AE-414E7F809CC3Q47251963-AA7263EB-8733-46EF-812F-0A6E83E81587Q50164785-25F220CA-229D-4949-BDBA-879F3CEC3DCAQ50733698-F65E2C0D-9520-4F16-9E03-69D415FB677AQ51927524-A46DA140-45D1-4A99-903E-2FB9BEC4D7E3Q53272892-26F26C9F-C5BD-4A94-A6B9-C047EEB7A696
P2860
Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cost effectiveness of smoking- ...... and implications for coverage.
@ast
Cost effectiveness of smoking- ...... and implications for coverage.
@en
Cost effectiveness of smoking- ...... and implications for coverage.
@nl
type
label
Cost effectiveness of smoking- ...... and implications for coverage.
@ast
Cost effectiveness of smoking- ...... and implications for coverage.
@en
Cost effectiveness of smoking- ...... and implications for coverage.
@nl
prefLabel
Cost effectiveness of smoking- ...... and implications for coverage.
@ast
Cost effectiveness of smoking- ...... and implications for coverage.
@en
Cost effectiveness of smoking- ...... and implications for coverage.
@nl
P1433
P1476
Cost effectiveness of smoking- ...... and implications for coverage.
@en
P2093
P304
P356
10.2165/00019053-199711060-00003
P577
1997-06-01T00:00:00Z
P6179
1013141539